Delving into the Latest Updates on Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker) with Synapse

Overview

Basic Info

Drug Type

Stem cell therapy

Synonyms-

Target-

Mechanism-

Therapeutic Areas

Immune System DiseasesRespiratory DiseasesOther Diseases

Active Indication

Pulmonary Alveolar Proteinosis, Acquired

Inactive Indication-

Originator Organization

Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.

Active Organization

Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.

Inactive Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

主要目的：评估自身免疫性肺泡蛋白沉积症（autoimmune pulmonary alveolar proteinosis，aPAP）患者接受人骨髓间充质干细胞（human Bone Marrow Mesenchymal Stem Cell，hBMMSC）注射液治疗的安全性和初步有效性。次要目的：评估aPAP患者经hBMMSC治疗后的长期安全性和有效性。

[Translation]

Primary objective: To evaluate the safety and preliminary efficacy of human bone marrow mesenchymal stem cell (hBMMSC) injection in patients with autoimmune pulmonary alveolar proteinosis (aPAP). Secondary objective: To evaluate the long-term safety and efficacy of hBMMSC in patients with aPAP.

Start Date-

Sponsor / Collaborator

Jiuzhitang Maker(Beijing)Cell Technology Co., Ltd.

100 Clinical Results associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)

Login to view more data

100 Translational Medicine associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)

Login to view more data

100 Patents (Medical) associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)

Login to view more data

100 Deals associated with Human Bone Marrow Mesenchymal Stem Cells (Jiuzhitang Maker)

Login to view more data